5 Value Stocks In The Healthcare Sector
Portfolio Pulse from Benzinga Insights
Benzinga Insights has identified five value stocks in the healthcare sector based on quantified analysis. These stocks include BioNTech, Pfizer, Zymeworks, Helius Medical Tech, and Dynavax Technologies.
May 29, 2023 | 2:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BioNTech is considered a value stock with a P/E of 3.95. Q1 earnings per share decreased by 76.72% compared to Q4.
BioNTech's low P/E ratio indicates it may be undervalued. However, the decrease in earnings per share may offset potential gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Dynavax Technologies is a value stock with a P/E of 7.1. The company reported a decrease in earnings per share from Q4 to Q1.
Dynavax Technologies' low P/E ratio indicates it may be undervalued, but the decrease in earnings per share may offset potential gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Zymeworks is a value stock with a P/E of 3.1. The company saw a decrease in earnings per share from Q4 to Q1.
Zymeworks' low P/E ratio indicates it may be undervalued, but the decrease in earnings per share may offset potential gains in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Helius Medical Tech is a value stock with a P/E of 8.0. The company experienced an increase in earnings per share from Q4 to Q1.
Helius Medical Tech's low P/E ratio and increased earnings per share make it an attractive value stock with potential for short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Pfizer is a value stock with a P/E of 7.46. The company experienced an increase in earnings per share and a higher dividend yield.
Pfizer's low P/E ratio and increased earnings per share, along with a higher dividend yield, make it an attractive value stock with potential for short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100